Biobanks as an important tool in modern translational oncology

Elena Petersen; Darya Chudakova; Evgeniya Shabalina; Artem Shiryaev; Nataliya Sukortseva; Gleb Zhemerikin; Pavel Karalkin; Igor Reshetov

doi:10.21638/spbu03.2022.405

Authors

Elena Petersen Moscow Institute of Physics and Technology, Institutskiy per., 9, Dolgoprudny, Moscow Region, 141701, Russian Federation https://orcid.org/0000-0002-8150-7553
Darya Chudakova Moscow Institute of Physics and Technology, Institutskiy per., 9, Dolgoprudny, Moscow Region, 141701, Russian Federation https://orcid.org/0000-0002-9354-6824
Evgeniya Shabalina Moscow Institute of Physics and Technology, Institutskiy per., 9, Dolgoprudny, Moscow Region, 141701, Russian Federation https://orcid.org/0000-0002-8184-7363
Artem Shiryaev Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), ul. Trubetskaya, 8–2, Moscow, 119991, Russian Federation https://orcid.org/0000-0001-9421-420X
Nataliya Sukortseva Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), ul. Trubetskaya, 8–2, Moscow, 119991, Russian Federation https://orcid.org/0000-0002-7704-1658
Gleb Zhemerikin Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), ul. Trubetskaya, 8–2, Moscow, 119991, Russian Federation https://orcid.org/0000-0002-4241-4856
Pavel Karalkin P.A. Herzen Moscow Research Institute of Oncology, 2 Botkinskiy proezd, 3, Moscow, 125284, Russian Federation https://orcid.org/0000-0002-2838-0776
Igor Reshetov Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), ul. Trubetskaya, 8–2, Moscow, 119991, Russian Federation https://orcid.org/0000-0002-0909-6278

DOI:

https://doi.org/10.21638/spbu03.2022.405

Abstract

The creation and use of biobanks is an actively growing field that plays an important role in the development of many branches of biotechnology and biomedicine, including oncology and translational medicine. In this review, based on the analysis of more than 80 Russian and foreign publications, we describe the current state of biobanking and its future perspectives. The diversity of biobanking and the problems arising from it, including the limits of applicability to different types of research, as well as the prospects for development are discussed. The role of biobanks in the study of malignant neoplasms, including rare/orphan diseases, and in the development of new diagnostic and therapeutic approaches, personalised medicine and pre-clinical screening studies, are highlighted.

Keywords:

biobank, biobanking, biotechnology, malignant tumors, translational medicine, personalised medicine, drug development, oncology

Downloads

Download data is not yet available.

References

Abdirahman, S. M., Christie, M., Preaudet, A., Burstroem, M. C. U., Mouradov, D., Lee, B., Sieber, O. M., and Putoczki, T. L. 2020. A Biobank of Colorectal Cancer Patient-Derived Xenografts. Cancers 12(9):2340. https://doi.org/10.3390/cancers12092340

Agca, Y. and Agca, C. 2021. Cryopreservation and transplantation of laboratory rodent ovarian tissue for genome banking and biomedical research; 469–483 in W. F. Wolkers and H. Oldenhof (eds) Cryopreservation and FreezeDrying Protocols. Springer US, New York, NY. https://doi.org/10.1007/978-1-0716-0783-1_22

Anisimov, S. V., Meshkov, A. N., Glotov, A. S., Borisova, A. L., Balanovsky, O. P., Belyaev, V. E., Granstrem, O. K., Grivtsova, L. Y., Efimenko, A. Y., and Pokrovskaya, M. S. 2021. National association of biobanks and biobanking specialists: new community for promoting biobanking ideas and projects in Russia. Biopreservation and biobanking 19(1):73–82. https://doi.org/10.1089/bio.2020.0049

Artene, S.-A., Ciurea, M. E., Purcaru, S. O., Tache, D. E., Tataranu, L. G., Lupu, M., and Dricu, A. 2013. Biobanking in a constantly developing medical world. The Scientific World Journal 2013. https://doi.org/10.1155/2013/343275

Arutyunyan, I., Elchaninov, A., Sukhikh, G., and Fatkhudinov, T. 2021. Cryopreservation of tissue-engineered scaffold-based constructs: from concept to reality. Stem Cell Reviews and Reports 1–19. https://doi.org/10.1007/s12015-021-10299-4

Ashcroft, J. W. and Macpherson, C. C. 2019. The complex ethical landscape of biobanking. The Lancet Public Health 4(6):e274-e275. https://doi.org/10.1016/S2468-2667(19)30081-7

Barchuk, A., Bespalov, A., Huhtala, H., Chimed, T., Belyaev, A., Moore, M., Anttila, A., Auvinen, A., Pearce, A., and Soerjomataram, I. 2019. Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001–2030. Scandinavian Journal of Public Health 47(5):482–491. https://doi.org/10.1177/1403494819845565

Baugh, J., Bartels, U., Leach, J., Jones, B., Chaney, B., Warren, K. E., Kirkendall, J., Doughman, R., Hawkins, C., and Miles, L. 2017. The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease. Journal of Neuro-Oncology 132(2):323–331. https://doi.org/10.1007/s11060-017-2372-5

Baust, J. M., Snyder, K. K., Van Buskirk, R. G., and Baust, J. G. 2022. Assessment of the impact of post-thaw stress pathway modulation on cell recovery following cryopreservation in a hematopoietic progenitor cell model. Cells 11(2):278. https://doi.org/10.3390/cells11020278

Bolck, H. A., Pauli, C., Göbel, E., Mühlbauer, K., Dettwiler, S., Moch, H., and Schraml, P. 2019. Cancer sample biobanking at the next level: combining tissue with living cell repositories to promote precision medicine. Frontiers in Cell and Developmental Biology 7. https://doi.org/10.3389/fcell.2019.00246

Boltanova, E. C. and Imekova, M. P. 2021. Types of biological databases (biobanks). Bulletin of Tomsk State University. Law. (41):136–148. (In Russian) https://doi.org/10.17223/22253513/41/12

Cao, J., Chan, W. C., and Chow, M. S. 2022. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives. International Journal of Oncology 60(5):1–13. https://doi.org/10.3892/ijo.2022.5342

Carvalho, D., Mackay, A., Temelso, S., Izquierdo, E., Fernandez, E. P., Rogers, R., Boult, J., Salom, J. F., Simon, N., and Clarke, M. 2020. MODL-20. A biobank of ~ 100 patient-derived models representing biological heterogeneity and distinct therapeutic dependencies in paediatric high grade glioma and DIPG. Neuro-Oncology 22(Supplement_3):iii414–iii415. https://doi.org/10.1093/neuonc/noaa222.593

Coppola, L., Cianflone, A., Grimaldi, A. M., Incoronato, M., Bevilacqua, P., Messina, F., Baselice, S., Soricelli, A., Mirabelli, P., and Salvatore, M. 2019. Biobanking in health care: evolution and future directions. Journal of Translational Medicine 17(1):1–18. https://doi.org/10.1186/s12967-019-1922-3

Danilova, A., Nekhaeva, T. L., Efremova, N. A., Maidin, M. A., Fedoros, E. I., and Baldueva, I. A. 2021. Development and characterisation of three-dimensional cellular models of solid tumors for individualization of treatment of cancer patients. Siberian Journal of Oncology 20(5):58–74. (In Russian) https://doi.org/10.21294/1814-4861-2021-20-5-58-74

Darrigues, E., Elberson, B. W., De Loose, A., Lee, M. P., Green, E., Benton, A. M., Sink, L. G., Scott, H., Gokden, M., Day, J. D., and Rodriguez, A. 2021. Brain tumor biobank development for precision medicine: role of the neurosurgeon. Frontiers in Oncology 11. https://doi.org/10.3389/fonc.2021.662260

Doludin, Y., Borisova, A., Pokrovskaya, M., Stefanyuk, O., Sivakova, O., Botsoeva, S., Meshkov, A., Metelskaya, V., and Drapkina, O. 2019. Current best practices and biobanking recomedations. Klinicheskaia Laboratornaia Diagnostika 64(12):769–776. https://doi.org/10.18821/0869-2084-2019-64-12-769-776

Dufour, C., Vasseur, R., Perbet, R., Leblond, P., Vinchon, M., Reyns, N., Touzet, G., Maurage, C.-A., Fabienne, E., and Florence, R. 2018. DIPG-44. Molecular and chromosomal characterization of a unique series of diffuse midline gliomas in children and young adults. Neuro-Oncology 20(Suppl 2):i57. https://doi.org/10.1093/neuonc/noy059.137

Ferreira, L. P., Gaspar, V. M., and Mano, J. F. 2020. Decellularized extracellular matrix for bioengineering physiomimetic 3D in vitro tumor models. Trends in Biotechnology 38(12):1397–1414. https://doi.org/10.1016/j.tibtech.2020.04.006

Flashner, S., Yan, K. S., and Nakagawa, H. 2021. 3D organoids: an untapped platform for studying host–microbiome interactions in esophageal cancers. Microorganisms 9(11):2182. https://doi.org/10.3390/microorganisms9112182

Foo, M. A., You, M., Chan, S. L., Sethi, G., Bonney, G. K., Yong, W.-P., Chow, E. K.-H., Fong, E. L. S., Wang, L., and Goh, B.-C. 2022. Clinical translation of patient-derived tumour organoids-bottlenecks and strategies. Biomarker Research 10(1):1–18. https://doi.org/10.1186/s40364022-00356-6

Garcia, M., Downs, J., Russell, A., and Wang, W. 2018. Impact of biobanks on research outcomes in rare diseases: a systematic review. Orphanet Journal of Rare Diseases 13(1):1–13. https://doi.org/10.1186/s13023-018-0942-z

Graham, C. E., Molster, C., Baynam, G. S., Bushby, K., Hansson, M., Mascalzoni, D., Kole, A., Mora, M., Monaco, L., and Bellgard, M. 2015. Current trends in biobanking for rare diseases: a review [Corrigendum]. Journal of Biorepository Science for Applied Medicine 3(1):1–2. https://doi.org/10.2147/BSAM.S83421

Golbin, D. A., Korochkina, A. L., Shugai, S. V., Tsukanova, T. V., Shifrin, M. A., Revischin, A. V., Kosyrkova, A. V., Danilov, G. V., Rybalkina, E. Y., Pavlova, G. V., and Kobyakov, G. L. 2020. Experience of creating a specialized biobank of human brain gliomas. Clinical and Experimental Morphology 9(4):39–49. (In Russian) https://doi.org/10.31088/CEM2020.9.4.39-49

Goncharova, A. S., Shevchenko, A. N., Dashkova, I. R., and Anisimov, A. E. 2021. Methodological aspects of the creation of patient-derived tumor xenografts. Kazan Medical Journal 102(5):694–702. (In Russian) https://doi.org/10.17816/KMJ2021-694

Gorbunova, E. 2020. Civil law regime of human biological material as an object of civil law: Russian and foreign experience. International Journal of the Humanities and Natural Sciences (11–4):63–67. (In Russian)

Griffin, C. P., Paul, C. L., Alexander, K. L., Walker, M. M., Hondermarck, H., and Lynam, J. 2021. Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole. NeuroOncology Advances 4(1). https://doi.org/10.1093/noajnl/vdab168

Gryshkov, O., Mutsenko, V., Tarusin, D., Khayyat, D., Barker, S.-A., Riabchenko, E., Nemirovska, Y., Danilov, A., Hagedorn, J., and Petrenko, A. 2021. Towards cryopreservation of scaffold-less and scaffold-based tissueengineered constructs. Cryobiology 103:184. https://doi.org/10.1016/j.cryobiol.2021.11.093

Jacob, F., Ming, G.-l., and Song, H. 2020. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing. Nature Protocols 15(12):4000–4033. https://doi.org/10.1038/s41596-020-0402-9

Jain, P. 2021. Could Biobanks Be the New Frontier for Digital Health Research? Vibrent Health argues that ongoing interactions between biobanks, researchers, and biospecimen donors can build trust and reinforce precision medicine. Genetic Engineering & Biotechnology News 41(11):22–23.

Jung, J. S., Choi, Y. S., Ahn, S. S., Yi, S., Kim, S. H., and Lee, S.-K. 2019. Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging. Neuroradiology 61(3):313–322. https://doi.org/10.1007/s00234-019-02154-8

Kahana-Edwin, S., Cain, L. E., and Karpelowsky, J. 2021. Roadmap to liquid biopsy biobanking from pediatric cancers — challenges and opportunities. Biopreservation and Biobanking 19(2):124–129. https://doi.org/10.1089/bio.2020.0117

Kamenski, P., Sazonov, A., Fedyanin, A., and Sadovnichy, V. 2016. Biological collections: Chasing the ideal. Acta Naturae 8(2):6–9. https://doi.org/10.32607/20758251-2016-8-2-6-9

Kanakoglou, D. S., Pampalou, A., Vrachnos, D. M., Karatrasoglou, E. A., Zouki, D. N., Dimonitsas, E., Klonou, A., Kokla, G., Theologi, V., and Christofidou, E. 2022. Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer. International Journal of Oncology 60(3):1–14. https://doi.org/10.3892/ijo.2022.5321

Kaprin, A. D., Ivanov, S. A., Petrov, V. A., Dukhova, N. N., Dvinskikh, N. I., Falaleeva, N. A., and Grivtsova, L. I. 2020. Biobanks in oncology: global experience and Russian reality. Journal of Modern Oncology 22(2):82–88. https://doi.org/10.26442/18151434.2020.2.200103

Khokhlov, A. L., Romanov, P. A., Mokhov, A. A., Pozdnyakov, N. O., Miroshnikov, A. E., and Yavorsky, A. N. 2021. Genetic research application in the study of pharmaceuticals. Kutafin Law Review 8(1):3–35. https://doi.org/10.17803/2313-5395.2021.1.15.003-035

Kiblitskaya, A., Shevchenko, A., Pandova, O., and Ardzha, A. 2021. Biobanking of patient-derived xenografts as a basis for translation research in oncology. Modern Problems of Science and Education 3:186. https://doi.org/10.17513/spno.30879

Kim, H., Zheng, S., Amini, S. S., Virk, S. M., Mikkelsen, T., Brat, D. J., Grimsby, J., Sougnez, C., Muller, F., and Hu, J. 2015. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution. Genome Research 25(3):316–327. https://doi.org/10.1101/gr.180612.114

Kit, O. I., Timofeeva, S. V., Sitkovskaya, A. O., Novikova, I. A., and Kolesnikov, E. N. 2022. The biobank of the National Medical Research Centre for Oncology as a resource for research in the field of personalized medicine: A review. Journal of Modern Oncology 24(1):6–11. https://doi.org/10.26442/18151434.2022.1.201384

Lapin, D. H., Tsoli, M., and Ziegler, D. S. 2017. Genomic insights into diffuse intrinsic pontine glioma. Frontiers in Oncology 7:57. https://doi.org/10.3389/fonc.2017.00057

Larsson, K., Höglund, M., Larsson, A., Thulin, M., and Karlsson, T. 2020. Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia. Growth Factors 38(3–4):189–196. https://doi.org/10.1080/08977194.2021.1932870

Lehmann, S., Guadagni, F., Moore, H., Ashton, G., Barnes, M., Benson, E., Clements, J., Koppandi, I., Coppola, D., and Demiroglu, S. Y. 2012. Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). Biopreservation and Biobanking 10(4):366–374. https://doi.org/10.1089/bio.2012.0012

Loft, S. and Poulsen, H. E. 1996. Cancer risk and oxidative DNA damage in man. Journal of Molecular Medicine 74(6):297– 312. https://doi.org/10.1007/BF00207507

Lommen, K., Odeh, S., de Theije, C. C., and Smits, K. M. 2020. Biobanking in molecular biomarker research for the early detection of cancer. Cancers 12(4):776. https://doi.org/10.3390/cancers12040776

Malsagova, K., Kopylov, A., Stepanov, A., Butkova, T., Sinitsyna, A., Izotov, A., and Kaysheva, A. 2020. Biobanks — a platform for scientific and biomedical research. Diagnostics 10(7):485. https://doi.org/10.3390/diagnostics10070485

Marderstein, A. R., Kulm, S., Peng, C., Tamimi, R., Clark, A. G., and Elemento, O. 2021. A polygenic-score-based approach for identification of gene-drug interactions stratifying breast cancer risk. The American Journal of Human Genetics 108(9):1752–1764. https://doi.org/10.1016/j.ajhg.2021.07.008

Matzke, L. A. and Watson, P. H. 2020. Biobanking for cancer biomarker research: issues and solutions. Biomarker Insights 15. https://doi.org/10.1177/1177271920965522

McInnes, G. and Altman, R. B. 2020. Drug response pharmacogenetics for 200,000 UK Biobank participants. Biocomputing 184–195. https://doi.org/10.1142/9789811232701_0018

Mikhailova, A., Nasykhova, Y. A., Muravyov, A., Efimenko, A. Y., and Glotov, A. 2020. Towards the creation of a unified glossary of Russian biobanks. Cardiovascular Therapy and Prevention 19(6):2710. https://doi.org/10.15829/1728-8800-2020-2710

Moore, H. M., Kelly, A. B., Jewell, S. D., McShane, L. M., Clark, D. P., Greenspan, R., Hayes, D. F., Hainaut, P., Kim, P., and Mansfield, E. 2011. Biospecimen reporting for improved study quality (BRISQ). Journal of Proteome Research 10(8):3429–3438. https://doi.org/10.1021/pr200021n

Mora, E. M., Álvarez-Cubela, S., and Oltra, E. 2015. Biobanking of exosomes in the era of precision medicine: are we there yet? International Journal of Molecular Sciences 17(1):13. https://doi.org/10.3390/ijms17010013

Nadelyaeva, I. 2020. Prospects for further development of biobanks and genetic research: ethical implications. REMEDIUM (4-6):6–15. https://doi.org/10.21518/1561-5936-2020-4-5-6-6-15

Nasarabadi, S., Hogan, M., and Nelson, J. 2018. Biobanking in precision medicine. Current Pharmacology Reports 4(1):91–101. https://doi.org/10.1007/s40495-018-0123-8

Palechor-Ceron, N., Krawczyk, E., Dakic, A., Simic, V., Yuan, H., Blancato, J., Wang, W., Hubbard, F., Zheng, Y.-L., and Dan, H. 2019. Conditional reprogramming for patient-derived cancer models and next-generation living biobanks. Cells 8(11):1327. https://doi.org/10.3390/cells8111327

Pernik, M. N., Bird, C. E., Traylor, J. I., Shi, D. D., Richardson, T. E., McBrayer, S. K., and Abdullah, K. G. 2021. Patient-derived cancer organoids for precision oncology treatment. Journal of Personalized Medicine 11(5):423. https://doi.org/10.3390/jpm11050423

Perrone, F. and Zilbauer, M. 2021. Biobanking of human gut organoids for translational research. Experimental & Molecular Medicine 53(10):1451–1458. https://doi.org/10.1038/s12276-021-00606-x

Petersen, E. V., Chudakova, D. A., Skorova, E. Y., Anikin, V., Reshetov, I. V., and Mynbaev, O. A. 2020. The extracellular matrix-derived biomarkers for diagnosis, prognosis, and personalized therapy of malignant tumors. Frontiers in Oncology 10:2792. https://doi.org/10.3389/fonc.2020.575569

Pinto, G., Saenz-de-Santa-Maria, I., Chastagner, P., Perthame, E., Delmas, C., Toulas, C., Moyal-Jonathan-Cohen, E., Brou, C., and Zurzolo, C. 2021. Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids. Biochemical Journal 478(1):21–39. https://doi.org/10.1042/BCJ20200710

Pogozhykh, D., Eicke, D., Gryshkov, O., Wolkers, W. F., Schulze, K., Guzmán, C. A., Blasczyk, R., and Figueiredo, C. 2020. Towards reduction or substitution of cytotoxic dmso in biobanking of functional bioengineered megakaryocytes. International Journal of Molecular Sciences 21(20):7654. https://doi.org/10.3390/ijms21207654

Regentova, O. S., Scherbenko, O. I., Dzhikiya, E. L., Zakharenko, M. V., Senchukova, A. L., Izmailov, T. R., Kulinich, T. M., and Bozhenko, V. K. 2020. The content and dynamics in the treatment of some molecular genetic markers in the blood plasma of patients with glial brain tumors according to the “liquid biopsy”. Bulletin of the Russian Scientific Center of Roentgenoradiology of the Ministry of Health of Russia 20(2):117–128. (In Russian)

Reznik, O. N., Kuzmin, D. O., Skvortsov, A. E., and Reznik, A. O. 2016. Biobanks — the invisible resource of transplantation. History, current state, prospects. Bulletin of Transplantology and Artificial Organs 18(4):123–132. (In Russian) https://doi.org/10.15825/1995-1191-2016-4-123-132

Rogers, J., Carolin, T., Vaught, J., and Compton, C. 2011. Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research. Journal of the National Cancer Institute Monographs 2011(42):32–38. https://doi.org/10.1093/jncimonographs/lgr010

Roumiantsev, P. O. and Mudunov, A. M. 2017. Biobanking in oncology and radiology. Endocrine Surgery 11(4):170– 177. https://doi.org/10.14341/serg9555

Ryan, M., Schloter, M., Berg, G., Kostic, T., Kinkel, L. L., Eversole, K., Macklin, J. A., Schelkle, B., Kazou, M., and Sarand, I. 2021. Development of microbiome biobanks– challenges and opportunities. Trends in Microbiology 29(2):89–92. https://doi.org/10.1016/j.tim.2020.06.009

Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., and Begthel, H. 2018. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172(1–2):373– 386. https://doi.org/10.1016/j.cell.2017.11.010

Skorova, E., Shabalina, E., Chudakova, D., Anikin, V., Reshetov, I., Mynbaev, O., and Petersen, E. 2020. Differential response to the high doses of dimethyl sulfoxide of the several human cancer cell lines cultured in 2D monolayer, decellularized matrix, and 3D spheroid cell culture systems. 7^th International Conference on Biomedical and Bioinformatics Engineering. https://doi.org/10.1145/3444884.3444916

Soboleva, M. E. 2021. Biobanks in the Russian Federation. Alley of Science 1(6):585–593. (In Russian)

Stiller, M., Sucker, A., Griewank, K., Aust, D., Baretton, G. B., Schadendorf, D., and Horn, S. 2016. Single-strand DNA library preparation improves sequencing of formalinfixed and paraffin-embedded (FFPE) cancer DNA. Oncotarget 7(37):59115. https://doi.org/10.18632/oncotarget.10827

Tripathy, S., Singh, S., and Das, S. K. 2022. Cryopreservation of mesenchymal stem cells (MSCs) derived from bone marrow with carbohydrate additive sucrose and dimethyl sulfoxide (DMSO); pp. 177–186 in Contemporary Medical Biotechnology Research for Human Healt. Elsevier. https://doi.org/10.1016/B978-0-323-91251-8.00013-1

Truong, J. X., Spotbeen, X., White, J., Swinnen, J. V., Butler, L. M., Snel, M. F., and Trim, P. J. 2021. Removal of optimal cutting temperature (OCT) compound from embedded tissue for MALDI imaging of lipids. Analytical and Bioanalytical Chemistry 413(10):2695–2708. https://doi.org/10.1007/s00216-020-03128-z

Turner, N., Sicari, B., Keane, T., Londono, R., Crapo, P., Tottey, S., and Badylak, S. 2012. Preparation of decellularized tissues: The importance of source animal age and thoroughness of decellularization upon the remodeling outcome. Journal of Tissue Enginering and Regenerative Medicine 6:171–171.

Vaes, R. D., van Dijk, D. P., Welbers, T. T., Blok, M. J., Aberle, M. R., Heij, L., Boj, S. F., Olde Damink, S. W., and Rensen, S. S. 2020. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer‐induced cachexia. Journal of Cachexia, Sarcopenia and Muscle 11(6):1509–1524. https://doi.org/10.1002/jcsm.12627

Velasquez, E., Szadai, L., Zhou, Q., Kim, Y., Pla, I., Sanchez, A., Appelqvist, R., Oskolas, H., Marko‐Varga, M., and Lee, B. 2021. A biobanking turning‐point in the use of formalin--fixed, paraffin tumor blocks to unveil kinase signaling in melanoma. Clinical and Translational Medicine 11(8). https://doi.org/10.1002/ctm2.466

Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., and Burke, R. 2018. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 359(6378):920–926. https://doi.org/10.1126/science.aao2774

Walter, I., Burger, S., Stargardt, M., Kummer, S., and Wieser, M. 2020. VetBiobank, Vetmeduni Vienna: A bioresource for clinical animal biospecimens. Open Journal of Bioresources 7(1). http://doi.org/10.5334/ojb.60

Wang, J., Shi, X., Xiong, M., Tan, W.-S., and Cai, H. 2022. Trehalose glycopolymers for cryopreservation of tissue-engineered constructs. Cryobiology 104:47–55. https://doi.org/10.1016/j.cryobiol.2021.11.004

Ward, T. H., Gilbert, D. C., Higginbotham, G., Morris, C. M., Speirs, V., and Curtin, N. J. 2022. Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations. The Journal of Pathology: Clinical Research 8(1):3–13. https://doi.org/10.1002/cjp2.246

Watling, C. Z., Schmidt, J. A., Dunneram, Y., Tong, T. Y., Kelly, R. K., Knuppel, A., Travis, R. C., Key, T. J., and Perez-Cornago, A. 2022. Risk of cancer in regular and low meat-eaters, fish-eaters, and vegetarians: a prospective analysis of UK Biobank participants. BMC Medicine 20(1):1–13. https://doi.org/10.1186/s12916-022-02256-w

Wei, X., Zhu, C., Ji, M., Fan, J., Xie, J., Huang, Y., Jiang, X., Xu, J., Yin, R., and Du, L. 2021. Diet and risk of incident lung cancer: a large prospective cohort study in UK biobank. The American Journal of Clinical Nutrition 114(6):2043– 2051. https://doi.org/10.1093/ajcn/nqab298

Wieser, V., Gaugg, I., Fleischer, M., Shivalingaiah, G., Wenzel, S., Sprung, S., Lax, S. F., Zeimet, A. G., Fiegl, H. and Marth, C. 2018. BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer. Oncotarget 9(25):17501.

Wirth, U., Garzetti, D., Jochum, L. M., Spriewald, S., Kühn, F., Ilmer, M., Lee, S. M., Niess, H., Bazhin, A. V., and Andrassy, J. 2020. Microbiome analysis from paired mucosal and fecal samples of a colorectal cancer biobank. Cancers 12(12):3702. https://doi.org/10.3390/cancers12123702

Yao, L., Zao, X.-L., Pan, X.-F., Zhang, H.-G., Wang, F.-J., and Qiao, P.-F. 2022. Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy. Journal of Chemotherapy 1–13. https://doi.org/10.1080/1120009X.2022.2045827

Zaikina, E. V. 2021. Evaluation of the revivability and growth dynamics of glioblastoma xenografts after cryopreservation. Nauka v XXI veke: Innovative Potential for Development, Sb. nauch. st. po materialam pyatoi Mezhd. nauchno-prakt. konf., pp. 8–12. Ufa. (In Russian)

Zhou, W., Kanai, M., Wu, K.-H. H., Rasheed, H., Tsuo, K., Hirbo, J. B., Wang, Y., Bhattacharya, A., Zhao, H., and Namba, S. 2022. Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease. Cell Genomics 2(10):100192. https://doi.org/10.1101/2021.11.19.21266436

Zinovieva, N. A., Fisinin, V. I., Bagirov, V. A., Kostyunina, O. V., and Gladyr, E. A. 2013. Bioresource centers as a form of conservation of genetic resources of agricultural animals. Achievements of Science and Technology of the Agroindustrial Complex 11:40–41. (In Russian)